By Hannah Elliott, Forbes Staff
Last week in California I drove an indigo blue Bentley GTC Speed from the Chateau Marmont in West Hollywood through Beverly Hills and down through Orange County near the surfer’s paradise of Salt Creek and Dana Point.
By Business Wirevia The Motley Fool
Filed under: Investing
Erickson Air-Crane to Webcast its Presentation at the 25 th Annual ROTH Conference
PORTLAND, Ore.–(BUSINESS WIRE)– Erickson Air-Crane, Inc. (NAS: EAC) , a leading operator and the manufacturer of the powerful heavy-lift helicopter, the Erickson S-64 Aircrane, announced today that it will be presenting at the 25th Annual ROTH Conference in Dana Point, California. The presentation is to be held at 10:30 a.m. PT (1:30 p.m. ET) on Wednesday, March 20, 2013.
Udo Rieder, the Company’s President and Chief Executive Officer, will deliver the Company presentation. A live webcast of the presentation can be accessed at investors.ericksonaircrane.com.
About Erickson Air-Crane Incorporated
Erickson Air-Crane specializes in the operation and manufacture of the Erickson S-64 Aircrane (the “Aircrane”), a versatile and powerful heavy-lift helicopter. The Aircrane has a lift capacity of up to 25,000 pounds and is the only commercial aircraft built specifically as a flying crane without a fuselage for internal loads. The Aircrane is also the only commercial heavy-lift helicopter with a rear load-facing cockpit, combining an unobstructed view and complete aircraft control for precision lift and load placement capabilities. Erickson Air-Crane owns and operates a fleet of 18 Aircranes, which are used to support a wide variety of government and commercial customers worldwide across a broad range of aerial services, including firefighting, timber harvesting, infrastructure construction, and crewing. Erickson Air-Crane also manufactures Aircranes and related components for sale to government and commercial customers and provides aftermarket support and maintenance, repair, and overhaul services for the Aircrane and other aircraft. Founded in 1971, Erickson Air-Crane is headquartered in Portland, Oregon with its principal manufacturing facility based in Central Point, Oregon. For more information, please visit http://www.ericksonaircrane.com.
Investor Relations
ICR
James Palczynski, +1 203-682-8229
jp@icrinc.com
KEYWORDS: United States North America California Oregon
INDUSTRY KEYWORDS:
The article Erickson Air-Crane to Webcast its Presentation at the 25th Annual ROTH Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
PCM to Present at Investor Conference
25 th Annual ROTH Conference
EL SEGUNDO, Calif.–(BUSINESS WIRE)– PCM, Inc. (NAS: PCMI) a leading technology solutions provider, announced today that Chief Executive Officer, Frank Khulusi, and its Chief Financial Officer, Brandon LaVerne, will present at The 25th Annual ROTH Conference taking place on March 17 – 20, 2013 at The Ritz Carlton, 1 Ritz Carlton Drive, Dana Point, California.
PCM’s presentation will take place on Tuesday, March 19, at 5:00pm Pacific in Track 2 Salon 3-Green.
The presentation will be webcast and will be available at the PCM investor relations website at investor.pcm.com.
About PCM, Inc.
PCM, Inc., through its wholly-owned subsidiaries, is a leading technology solutions provider to small and medium sized businesses, mid-market and enterprise customers, government and educational institutions and individual consumers. In the 12 months ended December 31, 2012, we generated approximately $1.4 billion in revenue and now have approximately 2,900 employees, over 68% of which are in sales or service positions. For more information please visit investor.pcm.com or call (310) 354-5600.
Genesis Select Corporation
Matt Selinger, Partner
(303) 415-0200
KEYWORDS: United States North America California
INDUSTRY KEYWORDS:
The article PCM to Present at Investor Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");
function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
…read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
On Assignment to Attend Roth Conference
CALABASAS, Calif.–(BUSINESS WIRE)– On Assignment, Inc. (NYS: ASGN) , a leading global provider of diversified professional staffing solutions, today announced that President and Chief Executive Officer Peter Dameris, and Chief Administrative Officer and Treasurer Jim Brill, are scheduled to make an investor presentation at The Roth 25th Annual OC Growth Stock Conference on March 19, 2013, 4:00 p.m. Pacific Time at The St. Regis Hotel in Dana Point, California.
Webcasts and presentations for this conference will be available on the Company web site at www.onassignment.com in the Investor Relations section under “Presentations.”
About On Assignment
On Assignment, Inc. (NYS: ASGN) , is a leading global provider of in-demand, skilled professionals in the growing technology, healthcare and life sciences sectors, where quality people are the key to success. The Company goes beyond matching résumés with job descriptions to match people they know into positions they understand for temporary, contract-to-hire, and direct hire assignments. Clients recognize On Assignment for their quality candidates, quick response, and successful assignments. Professionals think of On Assignment as career-building partners with the depth and breadth of experience to help them reach their goals.
On Assignment was founded in 1985 and went public in 1992. The corporate headquarters are located in Calabasas, California, with a network of approximately 130 branch offices throughout the United States, Canada, United Kingdom, Netherlands, Ireland and Belgium. Additionally, physician placements are made in Australia and New Zealand. To learn more, visit http://www.onassignment.com.
On Assignment, Inc.
Ed Pierce
Chief Financial Officer
818-878-7900
KEYWORDS: United States North America California
INDUSTRY KEYWORDS:
The article On Assignment to Attend Roth Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
…read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
DFC Global Corp. to Present at the 25 th Annual ROTH Conference
BERWYN, Pa.–(BUSINESS WIRE)– DFC Global Corp. (NAS: DLLR) , a leading international diversified financial services company serving primarily unbanked and under-banked consumers for over 30 years, announced today its Executive Vice President and Chief Financial Officer Randy Underwood and its President Ken Schwenke will be presenting at the 25th Annual ROTH Conference on Tuesday, March 19, 2013 at the Ritz Carlton in Dana Point, California. The presentation will begin at 4:00 PM Eastern Time.
About DFC Global Corp.
DFC Global Corp. is a leading international diversified financial services company serving primarily unbanked and under-banked consumers who, for reasons of convenience and accessibility, purchase some or all of their financial services from the Company rather than from banks and other financial institutions. Through its over 1,400 retail storefront locations and multiple Internet, mobile phone and other remote platforms, the Company provides a variety of consumer financial products and services in nine countries across North America and Europe—the United Kingdom, Canada, the United States, Sweden, Finland, Poland, Spain, Czech Republic and the Republic of Ireland. The Company believes that its customers, many of whom receive income on an irregular basis or from multiple employers, are drawn to the range of financial services it offers, the convenience of its products, the multiple ways in which they may conduct business with the Company and its high-quality customer service.
The Company’s products and services, principally its short-term single-payment consumer loans, secured pawn loans, check cashing services and gold buying services, provide customers with immediate access to cash for living expenses or other needs. The Company strives to offer its customers additional high-value ancillary services, including Western Union® money order and money transfer products, foreign currency exchange, reloadable VISA® and MasterCard® prepaid debit cards and electronic tax filing. In addition to its core retail products, the Company also provides fee-based services in the United States to enlisted military personnel applying for loans to purchase new and used vehicles that are funded and serviced under agreements with third-party lenders through the Company’s branded Military Installment Loan and Education Services, or MILES® program.
The Company’s networks of retail locations in the United Kingdom and Canada are the largest of their kind by revenue in each of those countries. The Company believes it is also the largest pawn lender in Europe by loan portfolio. As of December 31, 2012, the Company’s global retail operations consisted of 1,450 retail storefront locations, …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
Derma Sciences to Present at the 25 th Annual ROTH Conference
PRINCETON, N.J.–(BUSINESS WIRE)– Derma Sciences, Inc. (the “Company”) (NAS: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announced today that the Company will be presenting at the 25th Annual ROTH Conference on Tuesday, March 19 at 12:00 p.m. Pacific Time. The conference will be held at The Ritz-Carlton in Dana Point, Calif., from March 17 to 20, 2013.
To listen and view the presentation investors may visit the investor relations section of Derma Sciences‘ website at www.dermasciences.com. An archived copy of the presentation will also be available on Derma Sciences‘ website.
About Derma Sciences, Inc.
Derma Sciences is a medical technology company focused on three segments of the wound care marketplace: pharmaceutical wound care products, advanced wound care dressings to address chronic wounds, including diabetic ulcers and traditional dressings. The Company has begun Phase 3 clinical trials in diabetic foot ulcer healing with DSC127, based on excellent Phase 2 data. Its MEDIHONEY® product is the leading brand of honey-based dressings for the management of wounds and burns. The product has been shown to be effective in a variety of indications, and was the focus of a positive large-scale, randomized controlled trial involving 108 subjects with leg ulcers. TCC-EZ™ is its gold-standard total contact casting system for diabetic foot ulcers. Other novel products introduced into the $14 billion global wound care market include XTRASORB® for better management of wound exudate, and BIOGUARD® for infection prevention.
For more information please visit www.dermasciences.com.
Forward-Looking Statements
Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “expect,” “believe,” “anticipate,” “intend,” “could,” “estimate” or “continue” are intended to identify forward-looking statements. Readers are cautioned that certain important factors may affect the Company’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release or that are otherwise made by or on behalf of the Company. Factors that …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
OvaScience to Present at 25th Annual ROTH Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)– OvaScienceSM, (OTC: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, todayannounced that Michelle Dipp, M.D., Ph.D., Chief Executive Officer of OvaScience, will present at the 25th Annual ROTH Conference on Tuesday, March 19 at 8:30 a.m. at The Ritz Carlton in Dana Point, Calif.
A live audio webcast of the presentation can be accessed by visiting the Investor section of the Company’s website at www.ovascience.com. A replay of the webcast will be archived on the OvaScience website for two weeks following the presentation.
About OvaScience
OvaScience (OTC: OVSC) is a life sciences company focused on the discovery, development and commercialization of new treatments for infertility. The Company’s patented technology is based on the discovery of egg precursor cells (EggPCSM), which are found in the ovaries. By applying proprietary technology to identify and purify EggPCs, AUGMENTSM aims to improve egg quality and increase the success of in vitro fertilization (IVF). OvaScience’s team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine. For more information, please visit www.ovascience.com.
Forward-Looking Statements
This press release includes forward-looking statements about the Company’s strategy, future plans and prospects, including statements regarding the development of the Company’s product candidates, including AUGMENT. Any statements in this release about our strategy, plans, prospects and future expectations, financial position and operations, and other statements containing the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “aim,” “potential,” “will,” “would,” “could,” “should,” “continue,” and similar expressions, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: our expectations regarding the regulatory approvals required for AUGMENT; the science underlying our two product candidates, which is unproven; our ability to obtain, maintain and protect intellectual property utilized by our products; our ability to obtain additional funding to support our activities; our dependence on third parties; the successful development of, and ability to obtain regulatory approval for, our product candidates; our ability to commercialize our product candidates, including AUGMENT, on the timeline we expect, if at all; competition …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
Power Integrations CEO to Present at Roth Conference on March 18
SAN JOSE, Calif.–(BUSINESS WIRE)– Power Integrations (Nasdaq: POWI), the leader in high-voltage integrated circuits for energy-efficient power conversion, today announced that Balu Balakrishnan, the company’s president and CEO, will present at the 2013 Roth OC Growth Stock Conference in Dana Point, Calif. on March 18 at noon Pacific time. A live and archived webcast of the presentation will be available via the investor page of the company’s website, http://investors.powerint.com.
About Power Integrations
Power Integrations, Inc., is a Silicon Valley-based supplier of high-performance electronic components used in high-voltage power-conversion systems. The company’s integrated circuits and diodes enable compact, energy-efficient AC-DC power supplies for a vast range of electronic products including mobile devices, TVs, PCs, appliances, smart utility meters and LED lights. CONCEPT IGBT drivers enhance the efficiency, reliability and cost of high-power applications such as industrial motor drives, solar and wind energy systems, electric vehicles and high-voltage DC transmission. Since its introduction in 1998, Power Integrations‘ EcoSmart® energy-efficiency technology has prevented billions of dollars’ worth of energy waste and millions of tons of carbon emissions. Reflecting the environmental benefits of the company’s products, Power Integrations‘ stock is included in the NASDAQ® Clean Edge® Green Energy Index, The Cleantech Index®, and the Ardour Global IndexSM. For more information, including design-support tools and resources, please visit www.powerint.com; visit Power Integrations‘ Green Room for a comprehensive guide to energy-efficiency standards around the world.
Power Integrations, EcoSmart and the Power Integrations logo are trademarks or registered trademarks of Power Integrations, Inc. All other trademarks are property of their respective owners.
Power Integrations, Inc.
Joe Shiffler, 408-414-8528
jshiffler@powerint.com
KEYWORDS: United States North America California
INDUSTRY KEYWORDS:
The article Power Integrations CEO to Present at Roth Conference on March 18 originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
GSE Systems, Inc. to Present at Roth Capital Partners 25
th Annual OC Growth Conference
SYKESVILLE, Md.–(BUSINESS WIRE)– GSE Systems, Inc. (“GSE“) (NYSE MKT: GVP), a global energy services solutions provider, today announced that Jim Eberle, GSE‘s Chief Executive Officer, is scheduled to present at the Roth Capital Partners 25th Annual ROTH Conference on Wednesday, March 20, 2013 at 10:00 am PT / 1:00 pm ET. The event will be held at The Ritz Carlton in Dana Point, CA. A live webcast of the presentation will be available at http://wsw.com/webcast/roth27/gvp/.
About GSE Systems, Inc.
GSE Systems, Inc. is a world leader in real-time high-fidelity simulation, providing a wide range of simulation, training and engineering solutions to the energy and process industries. Its comprehensive and modular solutions help customers achieve performance excellence in design, training and operations. GSE‘s products and services are tailored to meet specific client requirements such as scope, budget and timeline. The Company has over four decades of experience, more than 1,100 installations, and hundreds of customers in over 50 countries spanning the globe. GSE Systems is headquartered in Sykesville (Baltimore), Maryland, with offices in St. Marys, Georgia; Madison, New Jersey; Cary, North Carolina; Chennai, India; Nyköping, Sweden; Stockton-on-Tees, UK; Glasgow, UK; and Beijing, China. Information about GSE Systems is available at www.gses.com.
FORWARD LOOKING STATEMENTS
We make statements in this press release that are considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. These statements reflect our current expectations concerning future events and results. We use words such as “expect,” “intend,” “believe,” “may,” “will,” “should,” “could,” “anticipates,” and similar expressions to identify forward-looking statements, but their absence does not mean a statement is not forward-looking. These statements are not guarantees of our future performance and are subject to risks, uncertainties, and other important factors that could cause our actual performance or achievements to be materially different from those we project. For a full discussion of these risks, uncertainties, and factors, we encourage you to read our documents on file with the Securities and Exchange Commission, including those set forth in our periodic reports under the …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
BioTime to Present at 25th Annual ROTH Conference
ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Dr. Michael D. West, Chief Executive Officer, will present a corporate overview of BioTime and its subsidiaries at the 25th Annual ROTH Conference. The presentation will take place on Monday, March 18, 2013 at 5:30 p.m. PDT at The Ritz-Carlton, Laguna Niguel, in Dana Point, California. The presentation will be webcast and available online at the “Investors” section of the website at www.biotimeinc.com and at http://wsw.com/webcast/roth27/btx/.
About BioTime, Inc.
BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem cell technologies is enhanced through subsidiaries focused on specific fields of application. BioTime develops and markets research products in the fields of stem cells and regenerative medicine, including a wide array of proprietary PureStem™ cell lines, HyStem® hydrogels, culture media, and differentiation kits. BioTime is developing Renevia™ (formerly known as HyStem®–Rx), a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. BioTime’s therapeutic product development strategy is pursued through subsidiaries that focus on specific organ systems and related diseases for which there is a high unmet medical need. BioTime’s majority-owned subsidiary Cell Cure Neurosciences Ltd. is developing therapeutic products derived from stem cells for the treatment of retinal and neural degenerative diseases. BioTime’s subsidiary OrthoCyte Corporation is developing therapeutic applications of stem cells to treat orthopedic diseases and injuries. Another subsidiary, OncoCyte Corporation, focuses on the diagnostic and therapeutic applications of stem cell technology in cancer, including the diagnostic product PanC-Dx™ currently being developed for the detection of cancer in blood samples. ReCyte Therapeutics, Inc. is developing applications of BioTime’s proprietary induced pluripotent stem cell technology to reverse the developmental aging of human cells to treat cardiovascular and blood cell diseases. BioTime’s subsidiary LifeMap Sciences, Inc. markets GeneCards®, the leading human gene database, as part of an integrated database suite that also includes the LifeMap Discovery™ database of embryonic development, stem cell research and regenerative medicine, and MalaCards, the human disease database. LifeMap Sciences also markets BioTime research products and PanDaTox, an innovative, recently developed, searchable database that can aid in the discovery of new antibiotics and biotechnologically beneficial products. BioTime Acquisition Corporation is a new subsidiary being used to acquire the stem cell …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
Broadwind Energy to Present at Roth Capital Partners 25 th Annual Growth Stock Conference
CICERO, Ill.–(BUSINESS WIRE)– Broadwind Energy, Inc. (NAS: BWEN) today announced that Peter Duprey, CEO, and Stephanie Kushner, CFO, will present at Roth Capital Partners‘ 25th Annual Growth Stock Conference in Dana Point, CA on Wednesday, March 20, 2013 at 11:00 a.m. local time. The presentation slides and a link to the webcast will be available on the investor page of http://bwen.com. Management will also be available for one-on-one meetings with investors attending the conference during the afternoon of Tuesday, March 19th and on Wednesday, March 20th.
About Broadwind Energy
Broadwind Energy (NAS: BWEN) applies decades of deep industrial expertise to innovate integrated solutions for customers in the energy and infrastructure markets. From gears and gearing systems for wind, oil and gas and mining applications to wind towers, to comprehensive remanufacturing of gearboxes and blades, to operations and maintenance services, and industrial weldments, we have solutions for the energy needs of the future. With facilities throughout the U.S., Broadwind Energy‘s talented team of 800 employees is committed to helping customers maximize performance of their investments – quicker, easier and smarter. Find out more at www.bwen.com.
Broadwind Energy, Inc.
Joni Konstantelos, 708.780.4819
joni.konstantelos@bwen.com
or
LHA
Jody Burfening/Carolyn Capaccio, 212.838.3777
ccapaccio@lhai.com
KEYWORDS: United States North America California Illinois
INDUSTRY KEYWORDS:
The article Broadwind Energy to Present at Roth Capital Partners 25th Annual Growth Stock Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
…read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
Cognex to Present at 25 th Annual Roth Conference
NATICK, Mass.–(BUSINESS WIRE)– Cognex Corporation (NAS: CGNX) announced today that Robert J. Shillman, Founder, Chairman and Chief Culture Officer of Cognex, will discuss the company’s performance and future prospects at the 25th Annual Roth Conference at The Ritz-Carlton, Laguna Niguel in Dana Point, California. Dr. Shillman’s presentation will be on Tuesday, March 19, 2013, beginning at 12:00 p.m. eastern time.
Internet users can listen to a real-time audio broadcast of the presentation, or an archived recording, on the Cognex Investor Relations website: http://www.cognex.com/Investor.
About Cognex Corporation
Cognex Corporation designs, develops, manufactures and markets a range of products that incorporate sophisticated machine vision technology that gives them the ability to “see.” Cognex products include barcode readers, machine vision sensors and machine vision systems that are used in factories, warehouses and distribution centers around the world to guide, gauge, inspect, identify and assure the quality of items during the manufacturing and distribution process. Cognex is the world’s leader in the machine vision industry, having shipped more than 850,000 vision-based products, representing over $3 billion in cumulative revenue, since the company’s founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has regional offices and distributors located throughout North America, Japan, Europe, Asia and Latin America. For details visit Cognex online at http://www.cognex.com.
Cognex Corporation
Susan Conway, 508-650-3353
Director of Investor Relations
susan.conway@cognex.com
KEYWORDS: United States North America Massachusetts
INDUSTRY KEYWORDS:
The article Cognex to Present at 25th Annual Roth Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");
By Business Wirevia The Motley Fool
Filed under: Investing
Lannett to Present at 25th Annual Roth Conference March 18
PHILADELPHIA–(BUSINESS WIRE)– Lannett Company, Inc. (NYSE MKT: LCI) today announced that the company will present at the 25th Annual Roth Conference on Monday, March 18, 2013, at 9:30 a.m. PT (12:30 p.m. ET) at The Ritz-Carlton Hotel in Dana Point, California.
Management will provide an overview of the company that will be available to interested parties through a live, listen-only audio web broadcast via the Internet at www.lannett.com. Listeners are encouraged to visit the web site at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software. The presentation will be archived and accessible on the web site for at least 30 days.
About Lannett Company, Inc.:
Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. For more information, visit the company’s website at www.lannett.com.
PondelWilkinson Inc.
Roger Pondel, (310) 279-5980
KEYWORDS: United States North America California Pennsylvania
INDUSTRY KEYWORDS:
The article Lannett to Present at 25th Annual Roth Conference March 18 originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
b.type=”text/javascript”;b.async=!0;b.src=(“https:”===c.location.protocol?”https:”:”http:”)+
‘//cdn.mxpnl.com/libs/mixpanel-2.2.min.js’;d=c.getElementsByTagName(“script”)[0];
d.parentNode.insertBefore(b,d);a._i=[];a.init=function(b,c,f){function d(a,b){
var c=b.split(“.”);2==c.length&&(a=a[c[0]],b=c[1]);a[b]=function(){a.push([b].concat(
Array.prototype.slice.call(arguments,0)))}}var g=a;”undefined”!==typeof f?g=a[f]=[]:
f=”mixpanel”;g.people=g.people||[];h=[‘disable’,’track’,’track_pageview’,’track_links’,
‘track_forms’,’register’,’register_once’,’unregister’,’identify’,’alias’,’name_tag’,
‘set_config’,’people.set’,’people.increment’];for(e=0;e<h.length;e++)d(g,h[e]);
a._i.push([b,c,f])};a.__SV=1.2;})(document,window.mixpanel||[]);
mixpanel.init("9659875b92ba8fa639ba476aedbb73b9");
function addEvent(obj, evType, fn, useCapture){
if (obj.addEventListener){
obj.addEventListener(evType, fn, useCapture);
return true;
} …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
RXi Pharmaceuticals to Present at the 25th Annual ROTH Conference
WESTBOROUGH, Mass.–(BUSINESS WIRE)– RXi Pharmaceuticals Corporation (OTC: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company’s President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the 25th Annual ROTH Conference on Tuesday, March 19th at 1:30pm PT. Dr. Cauwenbergh will discuss the development of RXI-109, a self-delivering RNAi compound designed to reduce dermal scarring, as well as business development opportunities with RXi’s sd-rxRNA® technology platform.
A live webcast of the presentation will be available on the “Investors” section of the Company’s website, www.rxipharma.com. A replay of the presentation will be available 90 days.
This conference is being held March 17-20, 2013 at the Ritz-Carlton Laguna Niguel in Dana Point, CA. For more information visit: http://www.roth.com.
About RXi Pharmaceuticals Corporation
RXi Pharmaceuticals Corporation (OTC: RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies based on its proprietary, self-delivering RNAi platform. Therapeutics that use RNA interference, or “RNAi,” have great promise because of their ability to down-regulate, the expression of a specific gene that may be over-expressed in a disease condition. Building on the pioneering work of scientific founder and Nobel Laureate Dr. Craig Mello, a member of the RXi Scientific Advisory Board, RXi’s first RNAi product candidate, RXI-109, which targets CTGF, entered into human clinical development in June 2012. For more information, please visit www.rxipharma.com.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future expectations, planned and future development of RXi Pharmaceuticals Corporation’s products and technologies. Forward-looking statements about expectations and development plans of RXi’s products involve significant risks, and uncertainties: risks that RXi may not be able to successfully develop its candidates, or that development of RNAi-based therapeutics may be delayed or not proceed as planned, or that we may not develop any RNAi-based product; risks that the development process for our product candidates may be delayed, risks related to development and commercialization of products by our competitors, risks related to our ability to control timing and terms of collaborations with third parties, and the possibility that other companies or organizations may assert …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
Dyax Corp. to Participate in the 25 th Annual ROTH Conference
BURLINGTON, Mass.–(BUSINESS WIRE)– Dyax Corp. (NAS: DYAX) announced today that the Company will participate in the 25th Annual ROTH Conference, being held March 17-20, 2013, at the Ritz-Carlton Laguna Niguel in Dana Point, CA. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Tuesday, March 19 at 5:30 PM (PT). Mr. Christensen will provide a corporate update regarding the Company’s key value drivers – KALBITOR® (ecallantide) and the angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).
This presentation will be webcast live and may be accessed by visiting the Investor Relations section of the company website at www.dyax.com. The webcast will also be available on the Dyax website for a limited period of time following the conferences.
About Dyax
Dyax is a fully integrated biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs. The Company’s key value drivers are the KALBITOR® (ecallantide) business and the angioedema portfolio, as well as the Licensing and Funded Research Program (LFRP).
Dyax developed KALBITOR on its own and, since February 2010, the Company has been selling it in the United States for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. Outside the United States, the Company has established partnerships to obtain regulatory approval for and commercialization of KALBITOR in certain markets and is evaluating opportunities in others.
The Company is currently developing products to expand its angioedema portfolio, including a suite of diagnostic assays to identify plasma kallikrein mediated (PKM) angioedema and a therapeutic candidate, DX-2930, for the prophylactic treatment of HAE.
KALBITOR and DX-2930 were identified using Dyax’s patented phage display technology, which rapidly selects compounds that bind with high affinity and specificity to therapeutic targets. Dyax leverages this technology broadly through the LFRP. This program has provided the Company a portfolio of product candidates being developed by its licensees, which currently includes 13 royalty and/or milestone bearing product candidates in various stages of clinical development, including three in Phase 3 trials.
Dyax is headquartered in Burlington, Massachusetts. For additional information about Dyax, please visit www.dyax.com.
Dyax …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
Pernix Therapeutics to Present at the 25th Annual ROTH Growth Conference
THE WOODLANDS, Texas–(BUSINESS WIRE)– Pernix Therapeutics Holdings, Inc. (NAS: PTX) , a specialty pharmaceutical company, today announced that Cooper Collins, President and Chief Executive Officer, will present at the 25th Annual ROTH Growth Stock Conference on Tuesday, March 19, 2013 at 9:30 a.m. PDT. The conference will be held at The Ritz Carlton in Dana Point, CA.
The presentation will be broadcast live over the Internet and can be accessed on the Company’s website, www.pernixtx.com, under “Webcasts and Presentation” on the investor relations section. The audio-recording of the presentation will be archived on the Company’s website for approximately 30 days following the conclusion of the presentation.
About Pernix Therapeutics Holdings, Inc.
Pernix Therapeutics is a specialty pharmaceutical company primarily focused on the sales, marketing, manufacturing and development of branded, generic and OTC pharmaceutical products. The Company manages a portfolio of branded products, including the recently acquired Hawthorn Pharmaceuticals‘ product line. The Company’s branded products for the pediatrics market include CEDAX®, an antibiotic for middle ear infections, NATROBA™, a topical treatment for head lice marketed under an exclusive co-promotion agreement with ParaPRO, LLC, and a family of treatments for cough and cold (ZUTRIPRO®, BROVEX®, ALDEX® and PEDIATEX®). The Company’s branded products for gastroenterology include OMECLAMOX-PAK®, a 10-day treatment for H. pylori infection and duodenal ulcer disease, and REZYST™, a probiotic blend to promote dietary management. The Company promotes its branded pediatric and gastroenterology products through its sales force. Pernix markets its generic products through its wholly-owned subsidiaries, Cypress Pharmaceutical and Macoven Pharmaceuticals. The Company’s wholly-owned subsidiary, Great Southern Laboratories, manufactures and packages products for the pharmaceutical industry in a wide range of dosage-forms. A product candidate utilizing cough-related intellectual property is in development for the U.S. OTC market. Founded in 1996, the Company is based in The Woodlands, TX.
Additional information about Pernix is available on the Company’s website located at www.pernixtx.com.
Pernix Therapeutics Holdings, Inc.
Joseph T. Schepers, 800-793-2145 ext. 3002
Director, Investor Relations
jschepers@pernixtx.com
KEYWORDS: United States North America California Texas
INDUSTRY KEYWORDS:
The article Pernix Therapeutics to Present at the 25th Annual …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
Exact Sciences to Participate in 25th Annual Roth Conference
MADISON, Wis.–(BUSINESS WIRE)– Exact Sciences Corp. (NAS: EXAS) today announced that it will present at the 25th Annual Roth Conference in Dana Point, Calif.
Maneesh K. Arora, Exact’s chief operating and chief financial officer, will make the company’s presentation at 1 p.m. PT on Monday, March 18.
A live webcast of the presentation will be available through the company’s website at www.exactsciences.com. An archive of the webcast will be available following the conclusion of the conference.
About Exact Sciences Corp.
Exact Sciences Corp. is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer. The company has exclusive intellectual property protecting its noninvasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer. For more information, please visit the company’s website at www.exactsciences.com.
Certain statements made in this news release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, that are intended to be covered by the “safe harbor” created by those sections. Forward-looking statements, which are based on certain assumptions and describe our future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “could,” “seek,” “intend,” “plan,” “estimate,” “anticipate” or other comparable terms. Forward-looking statements in this news release may address the following subjects among others: statements regarding the sufficiency of our capital resources, expected operating losses, anticipated results and timing of our pivotal clinical trial, expectations concerning our ability to secure FDA approval of our Cologuard test, expected license fee revenues, expected research and development expenses, expected general and administrative expenses and our expectations concerning our business strategy. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10-K and our subsequently filed Quarterly Reports on Form 10-Q. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to …read more
Source: FULL ARTICLE at DailyFinance
By Business Wirevia The Motley Fool
Filed under: Investing
SeaChange to Participate in March Investment Conferences
ACTON, Mass.–(BUSINESS WIRE)– SeaChange International (NAS: SEAC) , a leading global multi-screen video software innovator, announced that Chief Executive Officer Raghu Rau will participate in Northland Capital Markets’ 2013 Technology Conference in New York City on Wednesday, March 13th and the 25th Annual ROTH Conference in Dana Point, Calif., March 17-20. Mr. Rau’s presentation at the ROTH conference will be available live via webcast, as well as archived replay, on the investor relations section of SeaChange’s web site.
|
WHO: |
RaghuRau, CEO, SeaChange International |
|||
|
WHAT: |
…read more Source: FULL ARTICLE at DailyFinance |
By Business Wirevia The Motley Fool
Filed under: Investing
USA Technologies to Present at Three Upcoming Investor Conferences
MALVERN, Pa.–(BUSINESS WIRE)– USA Technologies, Inc. (NAS: USAT) , (“USAT”), a leader of wireless, cashless payment and M2M telemetry solutions for small-ticket, self-serve retailing industries, today announced that it will be presenting at three investor conferences in March—the Barrington Research Technology Conference in Chicago, Illinois, Northland Capital Markets’ Technology Conference in New York City, New York and the 25th Annual ROTH Conference in Dana Point, California. Details follow.
|
|
||
| Date: | Tuesday, March 12, 2013 | |
| Time: | 10:40 a.m. to 11:10 a.m. Central time | |
| Speaker: | Stephen P. Herbert, Chairman and CEO | |
By Business Wirevia The Motley Fool
Filed under: Investing
Glu Mobile to Present at 25th Annual ROTH Conference
SAN FRANCISCO–(BUSINESS WIRE)– Glu Mobile Inc., a leading global developer and publisher of freemium games for smartphone and tablet devices, today announced that its Chief Financial Officer, Eric R. Ludwig, is scheduled to present at the 25th Annual ROTH Conference in Dana Point, California on Monday, March 18, 2013 at 1:00 p.m. Pacific time (4:00 p.m. Eastern time).
A live webcast, as well as a replay, of the presentation will be available on the company’s investor relations website at http://www.glu.com/investors.
About Glu Mobile
Glu Mobile (NAS: GLUU) is a leading global developer and publisher of freemium games for smartphone and tablet devices. Glu is focused on creating compelling original IP games such as BLOOD & GLORY, DEER HUNTER, FRONTLINE COMMANDO, GUN BROS, and SAMURAI VS. ZOMBIES DEFENSE on a wide range of platforms including iOS, Android™, Windows Phone, Google Chrome, and MAC OS. Glu’s unique technology platform enables its titles to be accessible to a broad audience of consumers globally. Founded in 2001, Glu is headquartered in San Francisco with a major office outside Seattle, and international locations in Canada, China and Russia. Consumers can find high-quality entertainment wherever they see the ‘g’ character logo or at www.glu.com. For live updates, please follow Glu via Twitter at www.twitter.com/glumobile or become a Glu fan at www.facebook.com/glumobile.
BLOOD & GLORY, DEER HUNTER, FRONTLINE COMMANDO, GUN BROS, SAMURAI VS. ZOMBIES DEFENSE, GLU, GLU MOBILE and the ‘g’ character logo are trademarks of Glu Mobile Inc.
Media & Investor Relations:
ICR, Inc.
Seth Potter, 646-277-1230
ir@glu.com
KEYWORDS: United States North America California
INDUSTRY KEYWORDS:
The article Glu Mobile to Present at 25th Annual ROTH Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
(function(c,a){window.mixpanel=a;var b,d,h,e;b=c.createElement(“script”);
…read more
Source: FULL ARTICLE at DailyFinance
